M&A Deal Summary |
|
---|---|
Date | 2018-01-01 |
Target | New Vision Pharmaceuticals |
Sector | Life Science |
Buyer(s) | Morgan Stanley Tactical Value Investing |
Deal Type | Buyout (LBO, MBO, MBI) |
SEARCH BY
Category | Private Equity Firm |
---|---|
PE ASSETS | 1.4B USD |
Size | Large |
Type | Sector Agnostic |
Morgan Stanley Tactical Value Investing is an opportunistic investment group within Morgan Stanley focused on flexible capital solutions across asset classes, sectors, and geographies. The group will consider a variety of investment solutions including preferred equity, asset-backed loans, recapitalizations, PIPEs, and junior/senior debt. Morgan Stanley Tactical Value Investing is headquartered in New York City.
DEAL STATS | # |
---|---|
Overall | 5 of 15 |
Sector: Life Science M&A | 1 of 1 |
Type: Buyout (LBO, MBO, MBI) M&A Deals | 3 of 5 |
State: Florida M&A | 2 of 3 |
Country: United States M&A | 4 of 12 |
Year: 2018 M&A | 2 of 3 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2018-01-01 |
Unipharma
Tamarac, Florida, United States Unipharma is a healthcare packaging business that assists pharma and nutraceutical companies in the development, manufacturing and packaging of liquid, disposable, single-dosage units using “blow-fill-seal” (BFS) technology. Unipharma is based in Tamarac, Florida. |
Buy | - |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2018-06-06 |
Dataminr
New York, New York, United States Dataminr is an artificial intelligence (“A.I.”) platform detecting real-time, breaking news events for governments, corporates, financial firms and news agencies. Dataminr is based in New York city. |
Buy | - |